Literature DB >> 20382162

Crystal structure of the intermediate complex of the arginine repressor from Mycobacterium tuberculosis bound with its DNA operator reveals detailed mechanism of arginine repression.

Leonid T Cherney1, Maia M Cherney, Craig R Garen, Michael N G James.   

Abstract

The concentration of L-arginine in Mycobacterium tuberculosis (Mtb) and in many other bacteria is controlled by a transcriptional factor called the arginine repressor (ArgR). It regulates the transcription of the biosynthetic genes of the arginine operon by interacting with the approximately 16- to 20-bp ARG boxes in the promoter site of the operon. ArgRs in the arginine bound form are hexamers in which each protomer has two separately folded domains. The C-terminal domains form a hexameric core, whereas the N-terminal domains have the winged helix-turn-helix DNA-binding motif. Here, we present the crystal structure of the MtbArgR hexamer bound to three copies of the 16-bp DNA operator in the presence of trace amounts of L-arginine, determined to 2.15 A resolution. In contrast to our previously published structure of the ternary MtbArgR-DNA complex in the presence of 10 mM L-arginine, the DNA operators do not form a double ARG box in the structure reported here. The present structure not only retains the noncrystallographic 32 symmetry of the core (as in the earlier structure), but it also has the 3-fold axis for the whole complex. The core trimers are rotated relative to one another as in the other holo hexamers of MtbArgR, although the L-arginine ligands have only partial density and do not fully occupy the arginine-binding sites. Refinement of the occupancies and B-factors of ligands resulted in a value of approximately 4.4 arginine ligands per hexamer. This has allowed the dissociation constant of arginine from the arginine-binding site to be estimated. The present structure also has two protomer conformations, folded and extended. However, they are different from the conformations in the complex determined at an L-arginine concentration of 10 mM and do not form an interlocking arrangement. The new complex is less stable than the earlier described complex bound with nine arginine residues. Thus, the former can be considered as an intermediate in a pathway to the latter. On the basis of the structure of this intermediate complex, a more detailed mechanism of the arginine biosynthesis regulation in Mtb is proposed. Copyright (c) 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382162     DOI: 10.1016/j.jmb.2010.03.065

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  Contribution of YthA, a PspC Family Transcriptional Regulator of Lactococcus lactis F44 Acid Tolerance and Nisin Yield: a Transcriptomic Approach.

Authors:  Hao Wu; Jingui Liu; Sen Miao; Yue Zhao; Hongji Zhu; Mingqiang Qiao; Per Erik Joakim Saris; Jianjun Qiao
Journal:  Appl Environ Microbiol       Date:  2018-03-01       Impact factor: 4.792

2.  Metabolic engineering of Escherichia coli for efficient production of L-arginine.

Authors:  Hai-De Wang; Jian-Zhong Xu; Wei-Guo Zhang
Journal:  Appl Microbiol Biotechnol       Date:  2022-08-06       Impact factor: 5.560

Review 3.  Transcription factor-based biosensors enlightened by the analyte.

Authors:  Raul Fernandez-López; Raul Ruiz; Fernando de la Cruz; Gabriel Moncalián
Journal:  Front Microbiol       Date:  2015-07-01       Impact factor: 5.640

4.  Structural Analysis and Insights into the Oligomeric State of an Arginine-Dependent Transcriptional Regulator from Bacillus halodurans.

Authors:  Young Woo Park; Jina Kang; Hyun Ku Yeo; Jae Young Lee
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

5.  Conserved Dynamic Mechanism of Allosteric Response to L-arg in Divergent Bacterial Arginine Repressors.

Authors:  Saurabh Kumar Pandey; Milan Melichercik; David Řeha; Rüdiger H Ettrich; Jannette Carey
Journal:  Molecules       Date:  2020-05-10       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.